Login to Your Account

Cardio-Renal Player CorMedix Raises $12.5M in AMEX Debut

By Trista Morrison

Monday, March 29, 2010
CorMedix Inc. caught much of the biotech industry by surprise late Thursday when the relatively obscure cardio-renal specialty pharma firm priced a $12.5 million initial public offering on AMEX. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription